Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection
about
Antiviral Functions of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific IgG Antibodies: Effects of Antiretroviral Therapy and Implications for Therapeutic HIV-1 Vaccine Design.Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort.Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral TherapyStimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection.Antibody Responses After Analytic Treatment Interruption in Human Immunodeficiency Virus-1-Infected Individuals on Early Initiated Antiretroviral TherapyKey Concepts in the Early Immunology of HIV-1 Infection.Immunosuppressive Tryptophan Catabolism and Gut Mucosal Dysfunction Following Early HIV Infection.Antiretroviral therapy-induced functional modification of IgG4 and IgM responses in HIV-1-infected individuals screened by an allosteric biosensor.
P2860
Q33867299-08C27BA3-C24B-4D0D-94F9-65E21BEE3401Q34007084-FAB26436-836E-4332-8D42-A55B559BC35FQ34952914-DCA41337-A269-40C7-B131-C7355B293926Q36029177-9C0B7EE2-BA0A-4D1D-A8D5-14ED59852402Q36092497-B49A1E08-CA83-443F-86C6-CC966DFD5DF3Q36568672-D3D663D1-4BB4-4463-B572-E76C34062609Q37091564-24D1A42E-42D3-4C8F-B63A-B75663E7288AQ37971871-80358EE1-0672-434B-91D9-8C5E831B5743Q41524859-DCB7EA1E-B0AB-4AB4-AF52-A38D091CABB2Q46220045-7CB022A6-6720-458A-B4A2-4361A6B18640
P2860
Impact of highly active antiretroviral therapy on the maturation of anti-HIV-1 antibodies during primary HIV-1 infection
description
article
@en
im November 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Impact of highly active antire ...... during primary HIV-1 infection
@en
Impact of highly active antire ...... during primary HIV-1 infection
@nl
type
label
Impact of highly active antire ...... during primary HIV-1 infection
@en
Impact of highly active antire ...... during primary HIV-1 infection
@nl
prefLabel
Impact of highly active antire ...... during primary HIV-1 infection
@en
Impact of highly active antire ...... during primary HIV-1 infection
@nl
P2093
P2860
P1433
P1476
Impact of highly active antire ...... during primary HIV-1 infection
@en
P2093
L Adalid-Peralta
L Grangeot-Keros
R Krzysiek
P2860
P304
P356
10.1111/J.1468-1293.2006.00406.X
P577
2006-11-01T00:00:00Z